BioNexus Gene Lab Corp.
BGLC.US | Research and experimental development on natural sciences and engineering
BioNexus Gene Lab Corp. is a biotechnology company focused on molecular diagnostics and genetic testing services. The company develops and commercializes a range of diagnostic tests for various diseases, including infectious diseases, cancers, and inherited conditions. Their services include genetic...Show More
Better Health for All
0
No evidence available to assess BioNexus Gene Lab Corp on Better Health for All.
Fair Money & Economic Opportunity
0
BioNexus Gene Lab Corp. is a biotechnology company focused on molecular diagnostics and genetic testing services.
1
Its core business does not involve lending, insuring, moving, or storing money, nor does it offer consumer financial products or services. Therefore, all KPIs related to fair money and economic opportunity, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion for banking services, and product simplicity for financial products, are not applicable to the company's operations.
Fair Pay & Worker Respect
20
The company has an average employee rating of 4.3 out of 5 on Glassdoor, which translates to an 86% engagement score.
1
This includes a culture rating of 4.0 out of 5 and a work-life balance rating of 4.5 out of 5.
2
No other specific, quantitative data was found for the remaining KPIs.
Fair Trade & Ethical Sourcing
0
The provided articles do not contain specific, quantitative information regarding BioNexus Gene Lab Corp.'s fair trade and ethical sourcing practices. There is no evidence on the percentage of spend covered by fair-trade certifications, the frequency of supplier audits, any substantiated forced or child labor incidents, the traceability coverage of its supply chain, the speed of remediation for violations, the inclusion of ethical clauses in supplier contracts, the share of spend on high-risk materials, or the procurement budget directed to diverse suppliers.
1
Honest & Fair Business
0
No specific, quantifiable data points were provided in the article that directly map to the defined KPIs for Honest & Fair Business. The article mentions board resignations, an investigation into potential unauthorized proxy solicitation, shareholder rejection of proposals, and a change in quorum requirements.
1
However, these facts do not align with the quantitative thresholds required by the rubric's KPIs such as regulatory fines, transparency index scores, or percentages of conflict-free board members.
Kind to Animals
-30
The company's R&D activities, including pre-clinical and clinical trials, involve both in-vivo (animal) and in-vitro analyses, and the provision of animal models for immune responses.
1
Laboratory mice are used in early phase drug trials.
2
While big data and bioinformatics are noted as potential alternatives for human-centered data in drug research, the company's policy mentions pre-clinical testing lab services that include in-vivo analysis and animal models.
3
A BioNexus Status company, which BGLC.US is, must invest at least 3% of its annual revenue into R&D activities.
4
The company is listed as having "No Animal Exploitation" by crueltyfreeinvesting.org, but this conflicts with evidence of animal testing in pre-clinical trials and the use of laboratory mice.
5
No War, No Weapons
0
BioNexus Gene Lab Corp. (BGLC.US) is described as a biotechnology company focused on molecular diagnostics, genetic testing, chemical raw materials, and liquid biopsy tests.
1
The provided articles do not contain any evidence that the company is involved in arms manufacturing, military contracts, or conflict facilitation. There is no data indicating revenue from defense contracts, investment in dual-use technologies for military applications, sales to embargoed regimes, or any other activities related to war or weapons. Therefore, all KPIs are scored as 'N/A – no defense or arms-related activities in core business' or 'N/A – no applicable technology development/operations/exposure' based on the company's stated business model and the absence of contradictory evidence.
Planet-Friendly Business
0
No evidence available to assess BioNexus Gene Lab Corp on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess BioNexus Gene Lab Corp on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess BioNexus Gene Lab Corp on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No quantitative data, regulatory actions, violations, fines, certifications, awards, recognitions, industry benchmarks, or peer comparisons related to Zero Waste & Sustainable Products for BGLC.US were found in the provided articles.
1
The articles explicitly state that they do not contain any relevant data for the requested metrics.
2